T&R Biofab Co., Ltd. (KOSDAQ:246710)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec 31, 2023
Medical Engineering Devices Division	5.20B
Total	5.20B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec 31, 2023
South Korea	4.61B
Vietnam	462.15M
USA	150.17K
Philippines	82.51M
Japan	18.10M
Taiwan	20.35M
Europe	1.15M
Total	5.20B

Source: S&P Global Market Intelligence.